The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery
NCT ID: NCT04433338
Last Updated: 2025-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2020-09-29
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate the effect of preoperative weight loss by means of a 14-day low-calorie diet in bariatric patients on operative time, the ease of the Roux-en-Y gastric bypass (RYGB) procedure and long-term weight loss in a real-life experimental setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Dry Lean Body Mass as a Prognostic Factor for Excess Weight Loss After Bariatric Surgery.
NCT03558360
Direct Measurement of Food Intake Behaviour in Obese Women Before and After Bariatric Surgery or Lifestyle Intervention
NCT04990947
Ketogenic Diet Prior to Bariatric Surgery
NCT06850493
Physical Activity and Bariatric Surgery
NCT05050968
Nutritional Status of prEgnant Women Following BariatrIc surgEry
NCT06796829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Participants in the intervention group will follow a low-calorie diet during 14 days before undergoing surgery. The diet will consist of both meal replacements and regular foods.
For women, the diet provides ± 900 kcal, 50 grams of carbohydrates, 85 grams of protein, 30 grams of fat and 25 grams of fibres.
For men, the diet provides ± 1000 kcal, 55 grams of carbohydrates, 100 grams of protein, 30 grams of fat and 30 grams of fibres.
14-day Low Calorie Diet
Participants will be asked to:
* Use 4 (women) or 5 (men) Modifast meal replacements per day.
* Daily consume a minimum of 250 grams of (raw) vegetables without dressing.
* Daily consume 100 grams of lean meat/fish/meat analogues.
* Daily consume two spoons of liquid oil
* Daily drink at least 2.0 litres of water, coffee or tea without added sugar or milk, bouillon or sugar-free drinks.
Control group
Participants in the control group can eat according to the standard nutritional advices provided by their dietitian. These advices are intended to educate participants on the recommended eating pattern after surgery.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
14-day Low Calorie Diet
Participants will be asked to:
* Use 4 (women) or 5 (men) Modifast meal replacements per day.
* Daily consume a minimum of 250 grams of (raw) vegetables without dressing.
* Daily consume 100 grams of lean meat/fish/meat analogues.
* Daily consume two spoons of liquid oil
* Daily drink at least 2.0 litres of water, coffee or tea without added sugar or milk, bouillon or sugar-free drinks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to prepare the meal replacements at home
Exclusion Criteria
* Diabetes Mellitus
* Contraindication for the usage of Modifast meal replacements:
* Allergy or intolerance to any substance in the used meal replacements (Soy, milk, gluten, egg, peanuts, nuts and seeds)
* Veganism
* Kidney failure (GFR \< 90 ml/min/1.73m2), liver failure or cardiac insufficiency
* A heart attack (myocardial infarct) in the past twelve months
* Cancer
* Hypokalaemia: serum potassium level \<3.4 mmol/l
* Phenylketonuria \& Porphyria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric J Hazebroek, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Vitalys, part of Rijnstate hospital/Wageningen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rijnstate Hospital
Arnhem, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL70092.081.19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.